Evidence map›Paper›PMID 35280252›Full record

ArticleFrontiers in pharmacology2021

Effect of

Shanshan Nie, Kaifeng Chen, Chengxian Guo, Qi Pei, Chan Zou, Liangyuan Yao, Hongbo Yuan, Xia Zhao, Ran Xie, Xu He and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Shanshan NieCenter of Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, China.
Kaifeng ChenCenter of Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, China.
Chengxian GuoCenter of Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, China.
Qi PeiDepartment of Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, China.
Chan ZouCenter of Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, China.
Liangyuan YaoHunan Qianjin Xiangjiang Pharmaceutical Co., Ltd, Zhuzhou, China.
Hongbo YuanHunan Qianjin Xiangjiang Pharmaceutical Co., Ltd, Zhuzhou, China.
Xia ZhaoDepartment of Pharmacy, Peking University First Hospital, Beijing, China.
Ran XieDepartment of Pharmacy, Peking University First Hospital, Beijing, China.
Xu HeDepartment of Pharmacy, Peking University First Hospital, Beijing, China.
Jie HuangCenter of Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, China.
Guoping YangCenter of Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, China.
Third Xiangya Hospital · CNCentral South University · CNPeking University First Hospital · CNPeking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CYP4F2genetic polymorphismspharmacokineticssingle nucleotide polymorphismticagrelor

Identifiers

PMID35280252
PMCPMC8915292
OpenAlexW4214534498

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.